VEGFA and breast carcinoma: To further understand the TIF and plasma secretome in breast cancer, and the role of VEGF in modifying these secretomes, we characterized angiogenesis-related cytokines, small proteins and peptides in TIF from triple negative MDA-MB-231 and ER-positive MCF-7 human breast cancer xenografts with and without VEGF overexpression.